Highlights

[CARING] YoY TTM Result on 2015-08-31 [#1]

Stock [CARING]: CARING PHARMACY GROUP BHD
Announcement Date 28-Oct-2015
Admission Sponsor -
Sponsor -
Financial Year 31-May-2016
Quarter 31-Aug-2015  [#1]
Profit Trend QoQ -     3.61%    YoY -     29.86%
Quarter Report


View:


Show?  YoY % Horiz. %

TTM Result
31/08/18 31/08/17 31/08/16 31/08/15 31/08/14 31/08/13  -  CAGR
Revenue 526,220 474,265 426,064 370,857 343,449 0  -  -
  YoY % 10.95% 11.31% 14.89% 7.98% 0.00% - -
  Horiz. % 153.22% 138.09% 124.05% 107.98% 100.00% - -
PBT 30,131 26,362 12,643 18,794 16,620 0  -  -
  YoY % 14.30% 108.51% -32.73% 13.08% 0.00% - -
  Horiz. % 181.29% 158.62% 76.07% 113.08% 100.00% - -
Tax -6,394 -6,340 -3,792 -5,565 -5,429 0  -  -
  YoY % -0.85% -67.19% 31.86% -2.51% 0.00% - -
  Horiz. % 117.77% 116.78% 69.85% 102.51% 100.00% - -
NP 23,737 20,022 8,851 13,229 11,191 0  -  -
  YoY % 18.55% 126.21% -33.09% 18.21% 0.00% - -
  Horiz. % 212.11% 178.91% 79.09% 118.21% 100.00% - -
NP to SH 19,394 15,662 6,692 13,334 10,268 0  -  -
  YoY % 23.83% 134.04% -49.81% 29.86% 0.00% - -
  Horiz. % 188.88% 152.53% 65.17% 129.86% 100.00% - -
Tax Rate 21.22 % 24.05 % 29.99 % 29.61 % 32.67 % - %  -  % -
  YoY % -11.77% -19.81% 1.28% -9.37% 0.00% - -
  Horiz. % 64.95% 73.61% 91.80% 90.63% 100.00% - -
Total Cost 502,483 454,243 417,213 357,628 332,258 0  -  -
  YoY % 10.62% 8.88% 16.66% 7.64% 0.00% - -
  Horiz. % 151.23% 136.71% 125.57% 107.64% 100.00% - -
Net Worth 148,040 134,977 124,092 121,915 115,384 -  -  -
  YoY % 9.68% 8.77% 1.79% 5.66% 0.00% - -
  Horiz. % 128.30% 116.98% 107.55% 105.66% 100.00% - -
Dividend
31/08/18 31/08/17 31/08/16 31/08/15 31/08/14 31/08/13  -  CAGR
Div 17,416 9,796 3,265 4,354 6,531 0  -  -
  YoY % 77.78% 200.00% -25.00% -33.33% 0.00% - -
  Horiz. % 266.67% 150.00% 50.00% 66.67% 100.00% - -
Div Payout % 89.80 % 62.55 % 48.80 % 32.65 % 63.61 % - %  -  % -
  YoY % 43.57% 28.18% 49.46% -48.67% 0.00% - -
  Horiz. % 141.17% 98.33% 76.72% 51.33% 100.00% - -
Equity
31/08/18 31/08/17 31/08/16 31/08/15 31/08/14 31/08/13  -  CAGR
Net Worth 148,040 134,977 124,092 121,915 115,384 -  -  -
  YoY % 9.68% 8.77% 1.79% 5.66% 0.00% - -
  Horiz. % 128.30% 116.98% 107.55% 105.66% 100.00% - -
NOSH 217,706 217,706 217,706 217,706 217,706 -  -  -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% - -
  Horiz. % 100.00% 100.00% 100.00% 100.00% 100.00% - -
Ratio Analysis
31/08/18 31/08/17 31/08/16 31/08/15 31/08/14 31/08/13  -  CAGR
NP Margin 4.51 % 4.22 % 2.08 % 3.57 % 3.26 % - %  -  % -
  YoY % 6.87% 102.88% -41.74% 9.51% 0.00% - -
  Horiz. % 138.34% 129.45% 63.80% 109.51% 100.00% - -
ROE 13.10 % 11.60 % 5.39 % 10.94 % 8.90 % - %  -  % -
  YoY % 12.93% 115.21% -50.73% 22.92% 0.00% - -
  Horiz. % 147.19% 130.34% 60.56% 122.92% 100.00% - -
Per Share
31/08/18 31/08/17 31/08/16 31/08/15 31/08/14 31/08/13  -  CAGR
RPS 241.71 217.85 195.71 170.35 157.76 -  -  -
  YoY % 10.95% 11.31% 14.89% 7.98% 0.00% - -
  Horiz. % 153.21% 138.09% 124.06% 107.98% 100.00% - -
EPS 8.91 7.19 3.07 6.12 4.72 -  -  -
  YoY % 23.92% 134.20% -49.84% 29.66% 0.00% - -
  Horiz. % 188.77% 152.33% 65.04% 129.66% 100.00% - -
DPS 8.00 4.50 1.50 2.00 3.00 0.00  -  -
  YoY % 77.78% 200.00% -25.00% -33.33% 0.00% - -
  Horiz. % 266.67% 150.00% 50.00% 66.67% 100.00% - -
NAPS 0.6800 0.6200 0.5700 0.5600 0.5300 -  -  -
  YoY % 9.68% 8.77% 1.79% 5.66% 0.00% - -
  Horiz. % 128.30% 116.98% 107.55% 105.66% 100.00% - -
Adjusted Per Share Value based on latest NOSH - 217,706
31/08/18 31/08/17 31/08/16 31/08/15 31/08/14 31/08/13  -  CAGR
RPS 241.71 217.85 195.71 170.35 157.76 -  -  -
  YoY % 10.95% 11.31% 14.89% 7.98% 0.00% - -
  Horiz. % 153.21% 138.09% 124.06% 107.98% 100.00% - -
EPS 8.91 7.19 3.07 6.12 4.72 -  -  -
  YoY % 23.92% 134.20% -49.84% 29.66% 0.00% - -
  Horiz. % 188.77% 152.33% 65.04% 129.66% 100.00% - -
DPS 8.00 4.50 1.50 2.00 3.00 0.00  -  -
  YoY % 77.78% 200.00% -25.00% -33.33% 0.00% - -
  Horiz. % 266.67% 150.00% 50.00% 66.67% 100.00% - -
NAPS 0.6800 0.6200 0.5700 0.5600 0.5300 -  -  -
  YoY % 9.68% 8.77% 1.79% 5.66% 0.00% - -
  Horiz. % 128.30% 116.98% 107.55% 105.66% 100.00% - -
Price Multiplier on Financial Quarter End Date
31/08/18 31/08/17 31/08/16 31/08/15 31/08/14 31/08/13  -  CAGR
Date 30/08/18 30/08/17 30/08/16 28/08/15 29/08/14 -  -  -
Price 1.6900 1.7000 1.5600 1.2100 1.7900 0.0000  -  -
P/RPS 0.70 0.78 0.80 0.71 1.13 0.00  -  -
  YoY % -10.26% -2.50% 12.68% -37.17% 0.00% - -
  Horiz. % 61.95% 69.03% 70.80% 62.83% 100.00% - -
P/EPS 18.97 23.63 50.75 19.76 37.95 0.00  -  -
  YoY % -19.72% -53.44% 156.83% -47.93% 0.00% - -
  Horiz. % 49.99% 62.27% 133.73% 52.07% 100.00% - -
EY 5.27 4.23 1.97 5.06 2.63 0.00  -  -
  YoY % 24.59% 114.72% -61.07% 92.40% 0.00% - -
  Horiz. % 200.38% 160.84% 74.90% 192.40% 100.00% - -
DY 4.73 2.65 0.96 1.65 1.68 0.00  -  -
  YoY % 78.49% 176.04% -41.82% -1.79% 0.00% - -
  Horiz. % 281.55% 157.74% 57.14% 98.21% 100.00% - -
P/NAPS 2.49 2.74 2.74 2.16 3.38 0.00  -  -
  YoY % -9.12% 0.00% 26.85% -36.09% 0.00% - -
  Horiz. % 73.67% 81.07% 81.07% 63.91% 100.00% - -
Price Multiplier on Announcement Date
31/08/18 31/08/17 31/08/16 31/08/15 31/08/14 31/08/13  -  CAGR
Date 30/10/18 24/10/17 31/10/16 28/10/15 29/10/14 -  -  -
Price 1.7100 1.8000 1.4100 2.0600 1.5400 0.0000  -  -
P/RPS 0.71 0.83 0.72 1.21 0.98 0.00  -  -
  YoY % -14.46% 15.28% -40.50% 23.47% 0.00% - -
  Horiz. % 72.45% 84.69% 73.47% 123.47% 100.00% - -
P/EPS 19.20 25.02 45.87 33.63 32.65 0.00  -  -
  YoY % -23.26% -45.45% 36.40% 3.00% 0.00% - -
  Horiz. % 58.81% 76.63% 140.49% 103.00% 100.00% - -
EY 5.21 4.00 2.18 2.97 3.06 0.00  -  -
  YoY % 30.25% 83.49% -26.60% -2.94% 0.00% - -
  Horiz. % 170.26% 130.72% 71.24% 97.06% 100.00% - -
DY 4.68 2.50 1.06 0.97 1.95 0.00  -  -
  YoY % 87.20% 135.85% 9.28% -50.26% 0.00% - -
  Horiz. % 240.00% 128.21% 54.36% 49.74% 100.00% - -
P/NAPS 2.51 2.90 2.47 3.68 2.91 0.00  -  -
  YoY % -13.45% 17.41% -32.88% 26.46% 0.00% - -
  Horiz. % 86.25% 99.66% 84.88% 126.46% 100.00% - -

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
View candlestick stock charts with Technical indicators
MQ Affiliate
Be rewarded by being an MQ Affiliate
 
 

275  849  537  455 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 DNEX 0.30+0.04 
 DNEX-WD 0.06+0.015 
 BIOHLDG 0.295-0.005 
 XOX 0.08-0.01 
 PHB 0.0250.00 
 XOX-WC 0.020.00 
 LUSTER 0.195+0.01 
 VIZIONE 0.225-0.045 
 QES 0.365-0.015 
 AT 0.175-0.005 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Tan Sri Lim: “Being sick is being abnormal.” TOPGLOV allows only 2 paid sick leave p.a. LHL please make a police report if what you says is true! gloveharicut
2. Intco, Top Glove, Supermax - A Quick Comparison Trying to Make Sense Bursa Investments
3. Bargain hunting lifts GLOVEs share prices, say analyst, fund manager as situation remains 'volatile' gloveharicut
4. Jaks Resources - Final Update :- Jaks Hai Duong Power Plant achieved FULL COD ! DK
5. CIMB: FREIGHT is trading at a 60.9% & 30.8% discount to its local & regional peers gloveharicut
6. Eurocham: No mention of lockdown after Feb 4 in meeting with Miti save malaysia!
7. Health Ministry says govt not keen to implement MCO for a long period save malaysia!
8. Hartalega delivers record net profit in Q3 from higher sales volume gloveharicut
PARTNERS & BROKERS